William Stoops
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, William Stoops sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
William Stoops: 13 sponsored US clinical trials, 5 recruiting.
William Stoops sponsors 13 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cocaine Use Disorder, with 3 trials.
Top-decile sponsor footprint
William Stoops ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
13 total, page 1 of 1
Non-Abstinence Outcomes in Methamphetamine Use Disorder
NCT07226596
Cocaine and Pentoxifylline (BED IN 47)
NCT07086794
Methamphetamine and Troriluzole
NCT06989853
Suvorexant and Alcohol
NCT06326684
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
NCT05610072
Cocaine and Zolmitriptan
NCT05019430
Suvorexant and Cocaine
NCT03937986
Behavioral Effects of Drugs (Inpatient): 38
NCT03954938
Cocaine Use Reduction and Health
NCT03224546
Influence of n-Acetylcysteine Maintenance on Alcohol Effects
NCT03216954
Reinforcing Effects of Cocaine During Phendimetrazine Maintenance
NCT02522325
Phendimetrazine and Cocaine
NCT02233647
Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine
NCT01639157
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
Therapeutic Areas
What is open in the William Stoops pipeline
5 recruiting of 13 indexed (38% open); 7 completed (54%).
Phase mix: 0 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Cocaine Use Disorder (3 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
William Stoops: open-pipeline peers nationwide
Peers matched on 13 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
William Stoops sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 trials (± recruiting share)
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors near 38% open enrollment (± trial volume)
- Morehouse School of Medicine · 38% recruiting · 13 trials
- Northeastern University · 38% recruiting · 39 trials
- Thomas Hope · 38% recruiting · 13 trials
- Xenon Pharmaceuticals · 38% recruiting · 13 trials
Related
What to do with this William Stoops page
13 registered trials is a research-attention snapshot, not an endorsement of William Stoops or any single study.
- 5 of William Stoops's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cocaine Use Disorder is the condition William Stoops studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cocaine Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
William Stoops pipeline card: 13 registered trials from official public datasets.Report a data error.